PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Phenotype | C0011860|type 2 diabetes mellitus |
| Sentences | 19 |
| PubMedID- 22858312 | Association of manganese superoxide dismutase and glutathione s-transferases genotypes with myocardial infarction in patients with type 2 diabetes mellitus. |
| PubMedID- 24773097 | Incremental costs associated with myocardial infarction and stroke in patients with type 2 diabetes mellitus: an overview for economic modeling. |
| PubMedID- 20478050 | More data are required not only for efficacy, but also to address the long-term safety of rosiglitazone in these patients, particularly in light of the recent report that rosiglitazone is associated with a significant increase in the risk of myocardial infarction in patients with type 2 diabetes mellitus [55]. |
| PubMedID- 20484611 | Recent meta-analyses suggest an increased risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus (t2dm) treated with rosiglitazone. |
| PubMedID- 22679279 | Relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism, angiographically defined coronary artery disease and myocardial infarction in patients with type 2 diabetes mellitus. |
| PubMedID- 26410961 | The study included patients suffering myocardial infarction with and without type 2 diabetes mellitus. |
| PubMedID- 23226370 | Background: although the clinical outcome of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus (t2dm) is well established to be worse than for non-diabetic patients, the reasons for this remain unclear. |
| PubMedID- 20431807 | Materials and methods: 30 type 2 diabetes mellitus cases with myocardial infarction and equal members of type 2 diabetics without complications are enrolled. |
| PubMedID- 26543616 | We present one such unique case of a patient with an asymptomatic myocardial infarction complicated by vsr, type 2 diabetes mellitus and chronic bronchitis. |
| PubMedID- 24229770 | Although pioglitazone significantly prevented the progression of coronary atherosclerosis and reduced the recurrence of myocardial infarction in patients with type 2 diabetes mellitus (dm), it remains unclear whether pioglitazone could attenuate coronary artery inflammation. |
| PubMedID- 21907990 | We investigated whether snp rs4788102, which captures the entire sh2b1 variability, is associated with coronary artery disease (cad) and/or myocardial infarction (mi) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 22545680 | Better glycaemic control) was associated with a reduced risk of clinically evident microvascular complications and a nonsignificant reduction in the relative risk of myocardial infarction in patients with newly diagnosed type 2 diabetes mellitus [17]. |
| PubMedID- 26209521 | Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus. |
| PubMedID- 21576196 | An increased incidence of myocardial infarction with rosiglitazone in patients with type 2 diabetes mellitus (t2dm) has been reported. |
| PubMedID- 21444887 | Background: in the bypass angioplasty revascularization investigation 2 diabetes (bari 2d) trial, an initial strategy of coronary revascularization and optimal medical treatment (rev) compared with an initial optimal medical treatment with the option of subsequent revascularization (med) did not reduce all-cause mortality or the composite of cardiovascular death, myocardial infarction, and stroke in patients with type 2 diabetes mellitus and stable ischemic heart disease. |
| PubMedID- 19759031 | We compared lipids, lipid peroxidation product malondialdehyde (mda), the acute phase reactant high-sensitivity c-reactive protein (hscrp), interleukin 1beta (il-1beta), and platelet selectin (p-selectin) between healthy controls, type 2 diabetes mellitus (dm) participants without myocardial infarction (mi), as well as type 2 dm participants with mi. |
| PubMedID- 24529823 | Glycemic variability predicts cardiovascular complications in acute myocardial infarction patients with type 2 diabetes mellitus. |
| PubMedID- 23286208 | Furthermore, short- and long-term survival following a myocardial infarction is lower in patients with type 2 diabetes mellitus compared to those without[4-8]. |
| PubMedID- 26279482 | Aims: to assess the risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus treated with long-acting insulin analogues in comparison with other basal insulin therapy. |
Page: 1